Christopher Julian’s opioid journey is familiar to many Americans. He was prescribed painkillers as a teenager for a series of sports injuries. He said the doctor never warned him they could be addictive. Julian didn’t learn that fact until years later, when he was cut off and began suffering withdrawal symptoms. At that point, he…
By investing upfront in a more highly trained homecare workforce, states can avoid the massive costs associated with acute interventions and admissions to hospitals and residential facilities. The post States are Advancing Homecare’s Next Big Step — Paying Caregivers for Skill, Not Just Time appeared first on MedCity News.
States have begun to form “health alliances” as a counter to federal public health recommendations and policies under the Trump Administration. This Policy Watch describes the goals of these alliances, and discusses what effects they may have for U.S. public health policy.
Dupixent, a Sanofi and Regeneron Pharmaceuticals drug, is now approved for chronic obstructive pulmonary disease (COPD), a progressive lung disease prevalent in smokers. It’s the sixth FDA-approved indication for the blockbuster drug. The post Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD appeared first on MedCity News.
In 2019, Cristina Iglesias filed a lawsuit that changed the course of treatment for herself and other transgender inmates in federal custody. Iglesias, a trans woman who had been incarcerated for more than 25 years, was transferred from a men’s prison to a women’s one in 2021. And in 2022, she reached a landmark settlement…
That is the title of a fantastic editorial from Olivença et al. (2024). A lot of people when they look at pharmaceutical prices think they are ‘too high’ or ‘too low’. But the question is, too high or too low relative to what? What are our goals in pharmaceutical pricing. The editorial clearly articulates the…
As the industry continues to pour money into AI and other emerging technologies, a more disciplined era of healthcare technology investment is taking shape. The post The Hidden Million-Dollar Problem Lurking in Hospital Operations appeared first on MedCity News.
While hot-button health care issues such as abortion and the Affordable Care Act roil the presidential race, Democrats and Republicans in statehouses around the country have been quietly working together to tackle the nation’s medical debt crisis. New laws to curb aggressive hospital billing, to expand charity care for lower-income patients, and to rein in…
Through the convergence of proactive policy, advanced technology and strategic public-private partnerships, we can achieve this “no wrong door” vision and deliver a connected, streamlined social safety net that’s more efficient, economical, and effective. Here’s how. The post No Wrong Door: How Policy, Technology & Partnerships Can Power a Connected Social Safety Net appeared first…
The Trump administration’s broadsides against scientific research have caused unprecedented upheaval at the National Cancer Institute, the storied federal government research hub that has spearheaded advances against the disease for decades. NCI, which has long benefited from enthusiastic bipartisan support, now faces an exodus of clinicians, scientists, and other staffers — some fired, others leaving…